[Prolonged antihypertensive effect of beta-adrenolytic treatment with Visken in patients with essential hypertension].
D000328:Adult; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010869:Pindolol / Q000494:pharmacology / Q000627:therapeutic use*; D011311:Pressoreceptors / Q000187:drug effects
D010869:Pindolol
Przedłuzony wynik antyhipertensyjny leczenia beta-adrenolitycznego przy uzyciu preparatu Visken u chorych z nadciśnieniem samoistnym.